Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Other hematologic neoplasm 2Myeloid 2Lymphoid 2

Conditions

Myelodysplastic Syndromes 185Leukemia, Myeloid, Acute 165Precursor Cell Lymphoblastic Leukemia-Lymphoma 127Leukemia 116Leukemia, Lymphocytic, Chronic, B-Cell 95Hodgkin Disease 94Multiple Myeloma 92Lymphoma, Non-Hodgkin 89Myeloproliferative Disorders 86Lymphoma 77Leukemia, Myelogenous, Chronic, BCR-ABL Positive 75Lymphoma, Mantle-Cell 69Lymphoma, Follicular 69Congenital Abnormalities 68Leukemia, Myelomonocytic, Chronic 66Leukemia, Myeloid, Chronic-Phase 66Leukemia, Myeloid, Accelerated Phase 64Lymphoma, Large B-Cell, Diffuse 62Burkitt Lymphoma 62Lymphoma, B-Cell, Marginal Zone 61Primary Myelofibrosis 55Blast Crisis 52Lymphoma, Large-Cell, Immunoblastic 51Anemia, Refractory, with Excess of Blasts 47Neoplasms, Plasma Cell 46Myelodysplastic-Myeloproliferative Diseases 39Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 38Dendritic Cell Sarcoma, Interdigitating 37Waldenstrom Macroglobulinemia 34Recurrence 34

Interventions

Cyclophosphamide 3thymoglobulin 2fludarabine phosphate 2fludarabine 2Thiotepa 2Tacrolimus 2Rituximab 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Cytarabine 2plerixafor 1blinatumomab 1aldesleukin 1Transplantation 1Sirolimus 1Razoxane 1Mycophenolic Acid 1Mesna 1Interleukin-2 1Idarubicin 1Gemtuzumab 1Dexrazoxane 1Clofarabine 1Cladribine 1Busulfan 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Sarcoma, Myeloid × fludarabine phosphate × Myeloid × Clear all
NCT02790515 2025-08-12

Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
170 enrolled
LymphoidMyeloidOther hematologic neoplasmSarcoma

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Sarcoma, Myeloid, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT02259348 2017-05-30

Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation

St. Jude Children's Research Hospital

Phase 2 Terminated
12 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmSarcoma

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Sarcoma, Myeloid, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡